Loading…

Antifungal Activity of N -(4-Halobenzyl)amides against Candida spp. and Molecular Modeling Studies

Fungal infections remain a high-incidence worldwide health problem that is aggravated by limited therapeutic options and the emergence of drug-resistant strains. Cinnamic and benzoic acid amides have previously shown bioactivity against different species belonging to the genus. Here, 20 cinnamic and...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences 2021-12, Vol.23 (1), p.419
Main Authors: Perez-Castillo, Yunierkis, Montes, Ricardo Carneiro, da Silva, Cecília Rocha, Neto, João Batista de Andrade, Dias, Celidarque da Silva, Brunna Sucupira Duarte, Allana, Júnior, Hélio Vitoriano Nobre, de Sousa, Damião Pergentino
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c412t-2fd87f5d04caa616a23b6516629c3ebc061fd60fd630c899f995ae9d1c222ba03
cites cdi_FETCH-LOGICAL-c412t-2fd87f5d04caa616a23b6516629c3ebc061fd60fd630c899f995ae9d1c222ba03
container_end_page
container_issue 1
container_start_page 419
container_title International journal of molecular sciences
container_volume 23
creator Perez-Castillo, Yunierkis
Montes, Ricardo Carneiro
da Silva, Cecília Rocha
Neto, João Batista de Andrade
Dias, Celidarque da Silva
Brunna Sucupira Duarte, Allana
Júnior, Hélio Vitoriano Nobre
de Sousa, Damião Pergentino
description Fungal infections remain a high-incidence worldwide health problem that is aggravated by limited therapeutic options and the emergence of drug-resistant strains. Cinnamic and benzoic acid amides have previously shown bioactivity against different species belonging to the genus. Here, 20 cinnamic and benzoic acid amides were synthesized and tested for inhibition of ATCC 14243 and ATCC 22019. Five compounds inhibited the strains tested, with compound (MIC = 7.8 µg/mL) producing stronger antifungal activity than fluconazole (MIC = 16 µg/mL) against ATCC 14243. It was also tested against eight strains, including five clinical strains resistant to fluconazole, and showed an inhibitory effect against all strains tested (MIC = 85.3-341.3 µg/mL). The MIC value against ATCC 6258 was 85.3 mcg/mL, while against ATCC 14243, it was 10.9 times smaller. This strain had greater sensitivity to the antifungal action of compound . The inhibition of ATCC 14243 and ATCC 22019 was also achieved by compounds , , , and . Computational experiments combining target fishing, molecular docking and molecular dynamics simulations were performed to study the potential mechanism of action of compound against . From these, a multi-target mechanism of action is proposed for this compound that involves proteins related to critical cellular processes such as the redox balance, kinases-mediated signaling, protein folding and cell wall synthesis. The modeling results might guide future experiments focusing on the wet-lab investigation of the mechanism of action of this series of compounds, as well as on the optimization of their inhibitory potency.
doi_str_mv 10.3390/ijms23010419
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8745543</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2618239517</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-2fd87f5d04caa616a23b6516629c3ebc061fd60fd630c899f995ae9d1c222ba03</originalsourceid><addsrcrecordid>eNpdkcFrFDEUxkOx2Fq99SwBLy049SWZZCeXwrJUK1Q9qOfwJsmsWTLJOpkpbP_6jraWtYfH--D9-HgfHyGnDC6E0PAhbPrCBTComT4gx6zmvAJQixd7-oi8KmUDwAWX-iU5EhKgaWp5TNplGkM3pTVGurRjuA3jjuaOfqXVWV1dY8ytT3e7eI59cL5QXGNIZaQrTC44pGW7vaCzpl9y9HaKOMzK-RjSmn4fJxd8eU0OO4zFv3ncJ-Tnx6sfq-vq5tunz6vlTWVrxseKd65ZdNJBbREVU8hFqyRTimsrfGtBsc4pmEeAbbTutJbotWOWc94iiBNy-eC7ndreO-vTOGA02yH0OOxMxmD-v6Twy6zzrWkWtZS1mA3OHg2G_HvyZTR9KNbHiMnnqRiuWKNBKa1n9N0zdJOnIc3x_lJcaMkWM_X-gbJDLmXw3dMzDMyf8sx-eTP-dj_AE_yvLXEPYkeVeA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2618239517</pqid></control><display><type>article</type><title>Antifungal Activity of N -(4-Halobenzyl)amides against Candida spp. and Molecular Modeling Studies</title><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Perez-Castillo, Yunierkis ; Montes, Ricardo Carneiro ; da Silva, Cecília Rocha ; Neto, João Batista de Andrade ; Dias, Celidarque da Silva ; Brunna Sucupira Duarte, Allana ; Júnior, Hélio Vitoriano Nobre ; de Sousa, Damião Pergentino</creator><creatorcontrib>Perez-Castillo, Yunierkis ; Montes, Ricardo Carneiro ; da Silva, Cecília Rocha ; Neto, João Batista de Andrade ; Dias, Celidarque da Silva ; Brunna Sucupira Duarte, Allana ; Júnior, Hélio Vitoriano Nobre ; de Sousa, Damião Pergentino</creatorcontrib><description>Fungal infections remain a high-incidence worldwide health problem that is aggravated by limited therapeutic options and the emergence of drug-resistant strains. Cinnamic and benzoic acid amides have previously shown bioactivity against different species belonging to the genus. Here, 20 cinnamic and benzoic acid amides were synthesized and tested for inhibition of ATCC 14243 and ATCC 22019. Five compounds inhibited the strains tested, with compound (MIC = 7.8 µg/mL) producing stronger antifungal activity than fluconazole (MIC = 16 µg/mL) against ATCC 14243. It was also tested against eight strains, including five clinical strains resistant to fluconazole, and showed an inhibitory effect against all strains tested (MIC = 85.3-341.3 µg/mL). The MIC value against ATCC 6258 was 85.3 mcg/mL, while against ATCC 14243, it was 10.9 times smaller. This strain had greater sensitivity to the antifungal action of compound . The inhibition of ATCC 14243 and ATCC 22019 was also achieved by compounds , , , and . Computational experiments combining target fishing, molecular docking and molecular dynamics simulations were performed to study the potential mechanism of action of compound against . From these, a multi-target mechanism of action is proposed for this compound that involves proteins related to critical cellular processes such as the redox balance, kinases-mediated signaling, protein folding and cell wall synthesis. The modeling results might guide future experiments focusing on the wet-lab investigation of the mechanism of action of this series of compounds, as well as on the optimization of their inhibitory potency.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms23010419</identifier><identifier>PMID: 35008845</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Amides ; Amides - chemistry ; Amides - pharmacology ; Anti-Infective Agents - pharmacology ; Antifungal activity ; Antifungal agents ; Antifungal Agents - pharmacology ; Antimicrobial agents ; Benzoic acid ; Biological activity ; Candida ; Candida - drug effects ; Candida krusei ; Cell walls ; Computer applications ; Drug resistance ; Fluconazole ; Fungal infections ; Fungicides ; Halogenation ; Hydrogen bonds ; Ligands ; Microbial Sensitivity Tests ; Minimum inhibitory concentration ; Models, Molecular ; Molecular docking ; Molecular dynamics ; Molecular modelling ; Protein folding ; Proteins ; Simulation ; Thermodynamics</subject><ispartof>International journal of molecular sciences, 2021-12, Vol.23 (1), p.419</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-2fd87f5d04caa616a23b6516629c3ebc061fd60fd630c899f995ae9d1c222ba03</citedby><cites>FETCH-LOGICAL-c412t-2fd87f5d04caa616a23b6516629c3ebc061fd60fd630c899f995ae9d1c222ba03</cites><orcidid>0000-0001-6192-3691 ; 0000-0002-3710-0035 ; 0000-0001-7966-5635 ; 0000-0002-7180-4896</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2618239517/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2618239517?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,36992,38495,43874,44569,53769,53771,74158,74872</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35008845$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Perez-Castillo, Yunierkis</creatorcontrib><creatorcontrib>Montes, Ricardo Carneiro</creatorcontrib><creatorcontrib>da Silva, Cecília Rocha</creatorcontrib><creatorcontrib>Neto, João Batista de Andrade</creatorcontrib><creatorcontrib>Dias, Celidarque da Silva</creatorcontrib><creatorcontrib>Brunna Sucupira Duarte, Allana</creatorcontrib><creatorcontrib>Júnior, Hélio Vitoriano Nobre</creatorcontrib><creatorcontrib>de Sousa, Damião Pergentino</creatorcontrib><title>Antifungal Activity of N -(4-Halobenzyl)amides against Candida spp. and Molecular Modeling Studies</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Fungal infections remain a high-incidence worldwide health problem that is aggravated by limited therapeutic options and the emergence of drug-resistant strains. Cinnamic and benzoic acid amides have previously shown bioactivity against different species belonging to the genus. Here, 20 cinnamic and benzoic acid amides were synthesized and tested for inhibition of ATCC 14243 and ATCC 22019. Five compounds inhibited the strains tested, with compound (MIC = 7.8 µg/mL) producing stronger antifungal activity than fluconazole (MIC = 16 µg/mL) against ATCC 14243. It was also tested against eight strains, including five clinical strains resistant to fluconazole, and showed an inhibitory effect against all strains tested (MIC = 85.3-341.3 µg/mL). The MIC value against ATCC 6258 was 85.3 mcg/mL, while against ATCC 14243, it was 10.9 times smaller. This strain had greater sensitivity to the antifungal action of compound . The inhibition of ATCC 14243 and ATCC 22019 was also achieved by compounds , , , and . Computational experiments combining target fishing, molecular docking and molecular dynamics simulations were performed to study the potential mechanism of action of compound against . From these, a multi-target mechanism of action is proposed for this compound that involves proteins related to critical cellular processes such as the redox balance, kinases-mediated signaling, protein folding and cell wall synthesis. The modeling results might guide future experiments focusing on the wet-lab investigation of the mechanism of action of this series of compounds, as well as on the optimization of their inhibitory potency.</description><subject>Amides</subject><subject>Amides - chemistry</subject><subject>Amides - pharmacology</subject><subject>Anti-Infective Agents - pharmacology</subject><subject>Antifungal activity</subject><subject>Antifungal agents</subject><subject>Antifungal Agents - pharmacology</subject><subject>Antimicrobial agents</subject><subject>Benzoic acid</subject><subject>Biological activity</subject><subject>Candida</subject><subject>Candida - drug effects</subject><subject>Candida krusei</subject><subject>Cell walls</subject><subject>Computer applications</subject><subject>Drug resistance</subject><subject>Fluconazole</subject><subject>Fungal infections</subject><subject>Fungicides</subject><subject>Halogenation</subject><subject>Hydrogen bonds</subject><subject>Ligands</subject><subject>Microbial Sensitivity Tests</subject><subject>Minimum inhibitory concentration</subject><subject>Models, Molecular</subject><subject>Molecular docking</subject><subject>Molecular dynamics</subject><subject>Molecular modelling</subject><subject>Protein folding</subject><subject>Proteins</subject><subject>Simulation</subject><subject>Thermodynamics</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><recordid>eNpdkcFrFDEUxkOx2Fq99SwBLy049SWZZCeXwrJUK1Q9qOfwJsmsWTLJOpkpbP_6jraWtYfH--D9-HgfHyGnDC6E0PAhbPrCBTComT4gx6zmvAJQixd7-oi8KmUDwAWX-iU5EhKgaWp5TNplGkM3pTVGurRjuA3jjuaOfqXVWV1dY8ytT3e7eI59cL5QXGNIZaQrTC44pGW7vaCzpl9y9HaKOMzK-RjSmn4fJxd8eU0OO4zFv3ncJ-Tnx6sfq-vq5tunz6vlTWVrxseKd65ZdNJBbREVU8hFqyRTimsrfGtBsc4pmEeAbbTutJbotWOWc94iiBNy-eC7ndreO-vTOGA02yH0OOxMxmD-v6Twy6zzrWkWtZS1mA3OHg2G_HvyZTR9KNbHiMnnqRiuWKNBKa1n9N0zdJOnIc3x_lJcaMkWM_X-gbJDLmXw3dMzDMyf8sx-eTP-dj_AE_yvLXEPYkeVeA</recordid><startdate>20211231</startdate><enddate>20211231</enddate><creator>Perez-Castillo, Yunierkis</creator><creator>Montes, Ricardo Carneiro</creator><creator>da Silva, Cecília Rocha</creator><creator>Neto, João Batista de Andrade</creator><creator>Dias, Celidarque da Silva</creator><creator>Brunna Sucupira Duarte, Allana</creator><creator>Júnior, Hélio Vitoriano Nobre</creator><creator>de Sousa, Damião Pergentino</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6192-3691</orcidid><orcidid>https://orcid.org/0000-0002-3710-0035</orcidid><orcidid>https://orcid.org/0000-0001-7966-5635</orcidid><orcidid>https://orcid.org/0000-0002-7180-4896</orcidid></search><sort><creationdate>20211231</creationdate><title>Antifungal Activity of N -(4-Halobenzyl)amides against Candida spp. and Molecular Modeling Studies</title><author>Perez-Castillo, Yunierkis ; Montes, Ricardo Carneiro ; da Silva, Cecília Rocha ; Neto, João Batista de Andrade ; Dias, Celidarque da Silva ; Brunna Sucupira Duarte, Allana ; Júnior, Hélio Vitoriano Nobre ; de Sousa, Damião Pergentino</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-2fd87f5d04caa616a23b6516629c3ebc061fd60fd630c899f995ae9d1c222ba03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Amides</topic><topic>Amides - chemistry</topic><topic>Amides - pharmacology</topic><topic>Anti-Infective Agents - pharmacology</topic><topic>Antifungal activity</topic><topic>Antifungal agents</topic><topic>Antifungal Agents - pharmacology</topic><topic>Antimicrobial agents</topic><topic>Benzoic acid</topic><topic>Biological activity</topic><topic>Candida</topic><topic>Candida - drug effects</topic><topic>Candida krusei</topic><topic>Cell walls</topic><topic>Computer applications</topic><topic>Drug resistance</topic><topic>Fluconazole</topic><topic>Fungal infections</topic><topic>Fungicides</topic><topic>Halogenation</topic><topic>Hydrogen bonds</topic><topic>Ligands</topic><topic>Microbial Sensitivity Tests</topic><topic>Minimum inhibitory concentration</topic><topic>Models, Molecular</topic><topic>Molecular docking</topic><topic>Molecular dynamics</topic><topic>Molecular modelling</topic><topic>Protein folding</topic><topic>Proteins</topic><topic>Simulation</topic><topic>Thermodynamics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Perez-Castillo, Yunierkis</creatorcontrib><creatorcontrib>Montes, Ricardo Carneiro</creatorcontrib><creatorcontrib>da Silva, Cecília Rocha</creatorcontrib><creatorcontrib>Neto, João Batista de Andrade</creatorcontrib><creatorcontrib>Dias, Celidarque da Silva</creatorcontrib><creatorcontrib>Brunna Sucupira Duarte, Allana</creatorcontrib><creatorcontrib>Júnior, Hélio Vitoriano Nobre</creatorcontrib><creatorcontrib>de Sousa, Damião Pergentino</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Perez-Castillo, Yunierkis</au><au>Montes, Ricardo Carneiro</au><au>da Silva, Cecília Rocha</au><au>Neto, João Batista de Andrade</au><au>Dias, Celidarque da Silva</au><au>Brunna Sucupira Duarte, Allana</au><au>Júnior, Hélio Vitoriano Nobre</au><au>de Sousa, Damião Pergentino</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antifungal Activity of N -(4-Halobenzyl)amides against Candida spp. and Molecular Modeling Studies</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2021-12-31</date><risdate>2021</risdate><volume>23</volume><issue>1</issue><spage>419</spage><pages>419-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Fungal infections remain a high-incidence worldwide health problem that is aggravated by limited therapeutic options and the emergence of drug-resistant strains. Cinnamic and benzoic acid amides have previously shown bioactivity against different species belonging to the genus. Here, 20 cinnamic and benzoic acid amides were synthesized and tested for inhibition of ATCC 14243 and ATCC 22019. Five compounds inhibited the strains tested, with compound (MIC = 7.8 µg/mL) producing stronger antifungal activity than fluconazole (MIC = 16 µg/mL) against ATCC 14243. It was also tested against eight strains, including five clinical strains resistant to fluconazole, and showed an inhibitory effect against all strains tested (MIC = 85.3-341.3 µg/mL). The MIC value against ATCC 6258 was 85.3 mcg/mL, while against ATCC 14243, it was 10.9 times smaller. This strain had greater sensitivity to the antifungal action of compound . The inhibition of ATCC 14243 and ATCC 22019 was also achieved by compounds , , , and . Computational experiments combining target fishing, molecular docking and molecular dynamics simulations were performed to study the potential mechanism of action of compound against . From these, a multi-target mechanism of action is proposed for this compound that involves proteins related to critical cellular processes such as the redox balance, kinases-mediated signaling, protein folding and cell wall synthesis. The modeling results might guide future experiments focusing on the wet-lab investigation of the mechanism of action of this series of compounds, as well as on the optimization of their inhibitory potency.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>35008845</pmid><doi>10.3390/ijms23010419</doi><orcidid>https://orcid.org/0000-0001-6192-3691</orcidid><orcidid>https://orcid.org/0000-0002-3710-0035</orcidid><orcidid>https://orcid.org/0000-0001-7966-5635</orcidid><orcidid>https://orcid.org/0000-0002-7180-4896</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2021-12, Vol.23 (1), p.419
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8745543
source Publicly Available Content (ProQuest); PubMed Central; Coronavirus Research Database
subjects Amides
Amides - chemistry
Amides - pharmacology
Anti-Infective Agents - pharmacology
Antifungal activity
Antifungal agents
Antifungal Agents - pharmacology
Antimicrobial agents
Benzoic acid
Biological activity
Candida
Candida - drug effects
Candida krusei
Cell walls
Computer applications
Drug resistance
Fluconazole
Fungal infections
Fungicides
Halogenation
Hydrogen bonds
Ligands
Microbial Sensitivity Tests
Minimum inhibitory concentration
Models, Molecular
Molecular docking
Molecular dynamics
Molecular modelling
Protein folding
Proteins
Simulation
Thermodynamics
title Antifungal Activity of N -(4-Halobenzyl)amides against Candida spp. and Molecular Modeling Studies
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T00%3A13%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antifungal%20Activity%20of%20N%20-(4-Halobenzyl)amides%20against%20Candida%20spp.%20and%20Molecular%20Modeling%20Studies&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Perez-Castillo,%20Yunierkis&rft.date=2021-12-31&rft.volume=23&rft.issue=1&rft.spage=419&rft.pages=419-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms23010419&rft_dat=%3Cproquest_pubme%3E2618239517%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c412t-2fd87f5d04caa616a23b6516629c3ebc061fd60fd630c899f995ae9d1c222ba03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2618239517&rft_id=info:pmid/35008845&rfr_iscdi=true